Loading data
GENNasdaq
| Unit: USD | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|---|
| Revenue | 5 bn USD | 3.94 bn USD | 3.8 bn USD | 3.32 bn USD | 2.8 bn USD |
| Cost of revenue | 1.08 bn USD | 776 m USD | 731 m USD | 589 m USD | 408 m USD |
| Gross profit | 3.92 bn USD | 3.16 bn USD | 3.07 bn USD | 2.73 bn USD | 2.39 bn USD |
| Research and development expense | 409 m USD | 329 m USD | 332 m USD | 313 m USD | 253 m USD |
| Operating profit | 2.12 bn USD | 1.61 bn USD | 1.11 bn USD | 1.21 bn USD | 1.01 bn USD |
| Profit before tax | 1.51 bn USD | 1.03 bn USD | 447 m USD | 783 m USD | 1.04 bn USD |
| Income tax expense | 538 m USD | 386 m USD | -160 m USD | -551 m USD | 206 m USD |
| Net income (reported basis) | 973 m USD | 643 m USD | 607 m USD | 1.33 bn USD | 836 m USD |
| Basic earnings per share | 1.59 USD/share | 1.04 USD/share | 0.95 USD/share | 2.17 USD/share | 1.44 USD/share |
| Diluted earnings per share | 1.57 USD/share | 1.03 USD/share | 0.95 USD/share | 2.14 USD/share | 1.41 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.